Contracts › 36C24226N0741
36C24226N0741: Breyanzi Injection MM8684
Awarded to Bristol-Myers Squibb Company by Department of Veterans Affairs.
$0obligated
$364Kpotential value
31 October 2026current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 36C24226N0741 |
|---|---|
| Vehicle | 36F79724D0101 |
| Awardee | Bristol-Myers Squibb Company |
| Awarding agency | Department of Veterans Affairs |
| Awarding office | 242-NETWORK CONTRACT OFFICE 02 (36C242) |
| NAICS | 325412 Pharmaceutical Preparation Manufacturing |
| PSC | 6505 Drugs and Biologicals |
| Place of performance | NJ |
| Offers received | 1 |
| Period of performance | 27 August 2026 to 31 October 2026 |
| Potential end | 31 October 2026 |
| Estimated recompete solicitation | Now / imminent (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 325412 contracts · All expiring contracts · USASpending record